These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11068480

  • 21. [Generic drug substitution].
    Tamir O, Halkin H, Shemer J.
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [Abstract] [Full Text] [Related]

  • 22. Multisource drug policies in Latin America: survey of 10 countries.
    Homedes N, Ugalde A.
    Bull World Health Organ; 2005 Jan; 83(1):64-70. PubMed ID: 15682251
    [Abstract] [Full Text] [Related]

  • 23. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
    Hendeles L, Hochhaus G, Kazerounian S.
    Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
    [No Abstract] [Full Text] [Related]

  • 24. [Generic drugs in psychopharmacology: pros and cons].
    Cuenca E, Zaragozá F.
    Actas Esp Psiquiatr; 1999 Feb; 27(6):351-7. PubMed ID: 10611558
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
    Kasper S, Lentner S.
    Neuropsychiatr; 2008 Feb; 22(4):221-2. PubMed ID: 19080992
    [No Abstract] [Full Text] [Related]

  • 30. Physicians prefer greater detail in the biosimilar label (SmPC) - Results of a survey across seven European countries.
    Hallersten A, Fürst W, Mezzasalma R.
    Regul Toxicol Pharmacol; 2016 Jun; 77():275-81. PubMed ID: 27041395
    [Abstract] [Full Text] [Related]

  • 31. Basic facts about biosimilars.
    Nowicki M.
    Kidney Blood Press Res; 2007 Jun; 30(5):267-72. PubMed ID: 17622764
    [Abstract] [Full Text] [Related]

  • 32. Trying times for generic medicines in the USA.
    Lancet; 2013 Mar 30; 381(9872):1072. PubMed ID: 23540840
    [No Abstract] [Full Text] [Related]

  • 33. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane.
    Taylor PW, Keenan MH.
    Curr Med Res Opin; 2006 Mar 30; 22(3):603-15. PubMed ID: 16574043
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Main Reasons for Registration Application Refusal of Generic and Similar Pharmaceutical Drug Products by the Brazilian Health Regulatory Agency (ANVISA).
    do Carmo AC, Piras SS, Rocha NF, Gratieri T.
    Biomed Res Int; 2017 Mar 30; 2017():7894937. PubMed ID: 28280742
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Making medicines safe.
    Videau JY.
    Bull World Health Organ; 2001 Mar 30; 79(2):87. PubMed ID: 11242826
    [No Abstract] [Full Text] [Related]

  • 39. Impurities in generic pharmaceutical development.
    Kovaleski J, Kraut B, Mattiuz A, Giangiulio M, Brobst G, Cagno W, Kulkarni P, Rauch T.
    Adv Drug Deliv Rev; 2007 Jan 10; 59(1):56-63. PubMed ID: 17196702
    [Abstract] [Full Text] [Related]

  • 40. Quality of generic ophthalmic drugs.
    Novack GD.
    Ocul Surf; 2013 Jan 10; 11(1):54-6. PubMed ID: 23321360
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.